PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
120 hedge funds and large institutions have $248M invested in Provention Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
34% less capital invested
Capital invested by funds: $378M → $248M (-$130M)
Holders
120
Holding in Top 10
–
Calls
$8.85M
Puts
$2.61M
Top Buyers
| 1 | +$7.87M | |
| 2 | +$5.66M | |
| 3 | +$5.64M | |
| 4 |
Two Sigma Advisers
New York
|
+$3.45M |
| 5 |
Goldman Sachs
New York
|
+$2.81M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$7.51M | |
| 3 | -$4.32M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.44M |
| 5 |
6CM
683 Capital Management
New York
|
-$2.41M |